Dialysis Away: A Cloud Platform helping UK dialysis patients (a COVID-19 clinically extremely vulnerable group) to resume temporary treatment sustainably and safely away from their home clinic

Dialysis Away：一个云平台，帮助英国透析患者（COVID-19 临床上极其脆弱的群体）在远离家庭诊所的情况下可持续、安全地恢复临时治疗

• 批准号: 78633
• 金额: $ 17.83万
• 依托单位: MEDICALISYS LTD
• 依托单位国家: 英国
• 项目类别: Collaborative R&D
• 财政年份: 2020
• 资助国家: 英国
• 起止时间: 2020 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=78633
• 关键词: Dialysis; Away; Cloud; Platform; helping

Over 24,000 UK patients undergo in-clinic haemodialysis ("ICHD"), a complex, life-preserving treatment taking place 3 times per week. Many suffer from other conditions such as diabetes and hypertension.Prior to COVID, ICHD patients were able to dialyse away from their home clinic to visit family, friends or take a holiday. Given the commitments involved in their treatment, the ability to travel played an important role in increasing their quality of life.Whilst travel restrictions are easing for the healthy population, travel options for ICHD patients remain severely limited. Clinics are not currently accepting temporary patients, forcing ICHD patients to return to their home clinic every other day. There is likely to be a considerable lag before ICHD patients can travel as they did before and, should 2nd waves occur, this option will disappear once more unless clinics can find a way to process temporary treatments easily and safely. This threatens to leave many ICHD patients severely isolated.DialysisAway is designed to make the sending and receiving of temporary ICHD patients more viable in the new post- COVID-19 reality, helping ICHD patients to resume travel in the same way they did before.

超过24，000名英国患者接受门诊血液透析（“ICHD”），这是一种每周进行3次的复杂的维持生命治疗。许多人患有糖尿病和高血压等其他疾病。在COVID之前，ICHD患者能够离开家庭诊所进行透析，看望家人，朋友或度假。考虑到他们在治疗中的承诺，旅行的能力在提高他们的生活质量方面发挥了重要作用。虽然健康人群的旅行限制正在放松，但ICHD患者的旅行选择仍然非常有限。诊所目前不接受临时病人，迫使ICHD病人每隔一天回到他们的家庭诊所。在ICHD患者可以像以前那样旅行之前可能会有相当大的滞后，如果发生第二波，这种选择将再次消失，除非诊所能够找到一种方法来轻松安全地处理临时治疗。DialysisAway旨在使临时ICHD患者的发送和接收在新的后COVID-19现实中更加可行，帮助ICHD患者以与以前相同的方式恢复旅行。